Clinical Trials Browser

Phase 2 × Docetaxel × Tumor-Agnostic × Clear all

NCT00781612 2025-12-24

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT05027633 2025-11-19

Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)

Phase 2 Recruiting

Carcinoma, Squamous Cell

NCT07018570 2025-08-26

An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma

Phase 2 Recruiting

Adenocarcinoma

NCT05553808 2023-01-19

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Phase 2 Completed

105 enrolled 31 charts

Neoplasms

NCT01376310 2019-02-19

GSK1120212 Rollover Study

Phase 2 Terminated

159 enrolled 9 charts

Neoplasms

NCT00226239 2017-07-11

Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer

Phase 2 Completed

39 enrolled 10 charts

Neoplasms

NCT01472029 2017-06-19

HerFLOT

Phase 2 Completed

Adenocarcinoma

NCT00177255 2016-02-08

A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers

Phase 2 Terminated

40 enrolled 6 charts

Neoplasms

NCT00432315 2010-09-14

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Carcinoma, Squamous Cell